Australia’s Prospect Resources picks advisor for sale of Zimbabwe lithium mine

HARARE (Reuters) – Australian-listed Prospect Resources said on Monday it had picked Renaissance Securities Capital as its exclusive financial advisor for the possible sale of shares in Zimbabwe’s Arcadia Lithium mine to Russian energy firm Uranium One.

Uranium One, a unit of Russia’s state-owned nuclear energy firm Rosatom, agreed with Prospect last December to start talks towards buying equity in Arcadia and an offtake agreement.

Zimbabwe is pushing lithium as a major draw for investors as it looks to attract capital to its mining sector.

Prospect said in a statement that Renaissance Securities would advise “in relation to the potential sale, directly or indirectly, of the Company’s economic or other participation in, or the whole or part of the licence and/or the assets of, the Arcadia Lithium Project”.

Prospect said discussions with Uranium One were ongoing but there was no guarantee this would lead to a formal binding agreement.

In December, Prospect appointed African Export-Import Bank to arrange and syndicate a $143 million project finance debt facility for the Arcadia lithium project.


Partner Content

Mauritius-Africa, a partnership for shared prosperity

By: Mathieu Mandeng In the current complex and challenging circumstances that are testing the...

VIRTUAL VDJ EXPOSES LOCAL CREATIVE AND ENTERTAINMENT INDUSTRY

The City of eThekwini pulled out all stops to give fans of the annual Vodacom Durban July (VDJ). The Virtual Vodacom Durban...

GAUTRAIN – Why It Matters

Economic growth continues to be one of the focus areas for the Gauteng Provincial Government (GPG) and the Gautrain responds to that...

Tata International concludes a securitization transaction for its African Subsidiaries

UAE financial centers act as a gateway to benefit African businesses GCC, July 13th, 2020: Tata International Limited (TIL)...

Trending Now

Tech giants report strong earnings

The big four tech giants, worth nearly $5 trillion reported earnings last week defying the worst economic downturns on record. Joining CNBC Africa for more on the numbers is Henry Biddlecombe, Analyst at Anchor Capital.

Human trial for COVID-19 vaccine launched by Johnson & Johnson

Johnson & Johnson has confirmed that a human trial for a COVID-19 vaccine has begun in the United States and Belgium after positive results were seen in its study with monkeys.

SAVE CEO on the benefits of open banking amid COVID-19

COVID-19 has in a way increased the uptake of open banking solutions and with many consumers starting to use mediums such as services provided by fintechs, could this affect your banking choices, CNBC Africa spoke to the CEO and Founder of SAVE, Shema Steve for more.

Kenya’s domestic borrowings up in July amid COVID-19 response

Almost record monthly figures in regards to the Kenyan government borrowing marked the first month of the new fiscal year collecting over $2 billion through bills and Treasury bonds, but what does this mean if anything for the fiscal direction of Kenya, Callstreet Research Director, George Bodo spoke to CNBC Africa for more.

Subscribe to our newsletter

Sign up for free newsletters and get more CNBC AFRICA delivered to your inbox

- Advertisement -